Experts say the opioid crisis in America has damaged 2.4 million people, claimed 300,000 lives and has cost the country over $500 billion in economic harm. The damage — and an urgent quest to place civil and criminal blame for it — has created a fearsome time for general counsel and chief compliance officers at many U.S. companies that make, distribute or sell the drugs.

Increasingly general counsel are having to deal with criminal investigations and indictments of their drug companies, and sometimes of their own roles. One example was the indictment in April of the Rochester Drug Co-Operative in New York along with its chief compliance officer. In July prosecutors arrested the chief compliance officer of Miami-Luken Inc. for allegedly helping the company to illegally sell millions of dollars' worth of opioids.

Continue Reading for Free

Register and gain access to:

  • Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
  • Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Sue Reisinger

Senior reporter at ALM since 2004; based in Florida; covers general counsel and white collar crime; contact: [email protected]